These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 6390240)

  • 1. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T; Hoshino T
    No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
    Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
    Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell kinetics of glial tumors.
    Hoshino T
    Rev Neurol (Paris); 1992; 148(6-7):396-401. PubMed ID: 1448658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
    Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
    Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody].
    Sasaki K; Murakami T; Takahashi M
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2338-44. PubMed ID: 2751315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
    J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
    Maeda T; Hoshino T
    No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.
    Nagashima T; Hoshino T
    Acta Neuropathol; 1985; 66(1):12-7. PubMed ID: 3993331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
    Gunduz N
    Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric measurement of RNA synthesis using bromouridine labelling and bromodeoxyuridine antibodies.
    Jensen PO; Larsen J; Christiansen J; Larsen JK
    Cytometry; 1993; 14(4):455-8. PubMed ID: 7685681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro proliferation of human lymphocytes measured by an enzyme immunoassay using an anti-5-bromo-2-deoxyuridine monoclonal antibody.
    Martinon F; Rabian C; Loiseau P; Ternynck T; Avrameas S; Colombani J
    J Clin Lab Immunol; 1987 Jul; 23(3):153-9. PubMed ID: 3312611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
    Asai A; Shibui S; Barker M; Vanderlaan M; Gray JW; Hoshino T
    J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry.
    Begg AC; Hofland I
    Cytometry; 1991; 12(5):445-54. PubMed ID: 1718673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical results obtained with bromodeoxy uridine (BUdR) labelled tumors of the head and neck].
    Radner H; Kärcher H
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(2):116-21. PubMed ID: 2102412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
    Nagashima T; Hoshino T
    No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
    Nishizaki T; Orita T; Furutani Y; Ikeyama Y; Aoki H; Sasaki K
    J Neurosurg; 1989 Mar; 70(3):379-84. PubMed ID: 2536805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody.
    Nishizaki T; Orita T; Saiki M; Furutani Y; Aoki H
    J Neurosurg; 1988 Sep; 69(3):371-4. PubMed ID: 3404235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
    Lamborn KR; Prados MD; Kaplan SB; Davis RL
    Cancer; 1999 Feb; 85(4):925-35. PubMed ID: 10091772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.